About Us

Meet StemXO’s Advisory Team

SF

Sabine Flenady

Sabine Flenady is a cancer-biology researcher with experience in chronic lymphocytic leukemia and cellular immunity. She co-authored a study at Paracelsus Medical University in Austria examining CD1d expression in chronic lymphocytic leukemia and its relationship to disease progression and T-cell populations. Her professional profile describes postdoctoral research and laboratory-management experience, including tissue culture, flow cytometry and gene-expression analysis.

SJ

Sehwan Jang

Sehwan Jang, PhD, is a molecular biologist and biochemist whose research examines mitochondrial dysfunction in cardiovascular disease. His work includes oxidative stress, mitochondrial respiratory supercomplexes and heart failure. His institutional biography describes research at the National Institutes of Health and the National Institute on Alcohol Abuse and Alcoholism, followed by mitochondrial research at the University of Puerto Rico Medical Sciences Campus. His publications explore mitochondrial function and energy-producing respiratory complexes in cardiac cells.

Ivan Lugo

Ivan Lugo

Ivan Lugo is a Puerto Rico-based pharmaceutical and life-sciences executive with extensive experience in biopharmaceutical manufacturing and industry development. He served as executive director of INDUNIV, the Industry University Research Center, which promotes collaboration among industry, government and academia. In a 2019 interview, he described more than 40 years of global pharmaceutical experience and INDUNIV’s work supporting biotechnology innovation, manufacturing capabilities and emerging life-sciences companies in Puerto Rico. INDUNIV also lists him as a director.

Dr. Nagy Habib, MD

Dr. Nagy Habib, MD

Professor Nagy Habib, MD, is the Lead Clinician and Head of the Department of Hepatobilliary Surgery at Imperial College, London. A leading translational researcher on liver cancer and its treatment, he pioneered the first clinical trial in the use of adenovirus and plasmid for the treatment of liver cancer, as well as the use of plasmid gene therapy in hydrodynamic gene delivery. He is the first person in the West to publish a clinical trial on the use of adult bone marrow derived stem cells for the treatment of patients with liver insufficiency. He has published on the evolution of molecular biology of tumors from oncogene, tumor suppressor gene, epigenetic modification, gene therapy, stem cell therapy, RNA and saRNA (small activating RNA) and RNA aptamers. He is the inventor of, and was co-author of the first publication about the use of radiofrequency in devices used in liver surgery (Habib 4X), as well as interventional endoscopy (Habib EndoHPB) and interventional radiology (Habib Percutaneous HPB, Habib VesCoag, Habib VesOpen). He holds a gold award from the Advisory Committee for Clinical Excellence, and was named as one of Britain’s top surgeons in December 2011 by the Saturday Times Magazine. In December 2012, he was awarded the TAKREEM AWARD for Science and Technology for scientific work in liver cancer and the technological development of the Habib 4X surgical device.

Dr. Jayakumar Rajadas, Ph.D

Dr. Jayakumar Rajadas, Ph.D

Dr. Jayakumar Rajadas, Ph.D. is a Professor of biomedical engineering, Stanford University. He is the director of the Stanford Biomaterials and Advanced Drug Delivery Laboratory.

Dr. Nitin Shah, M.D

Dr. Nitin Shah, M.D

Chief of surgical ICU, Long Beach Veterans Healthcare. An anesthesiologist, critical care specialist, and professor of anesthesiology at Loma Linda University, Dr. Shah has over 20 years of experience as a practicing physician. He has led numerous clinical trials and participated in surgical missions around the globe.

AB

Dr. Alexander Bystritsky, M.D., Ph.D

Professor Emeritus of Psychiatry and Biobehavioral Sciences in the Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, where he is Emeritus Director for the Anxiety Disorders Program and Targeted Brain Stimulation Program. Dr. Bystritsky has published over 240 peer-reviewed papers, book chapters and short publications and has served as the PI and Co-PI on several NIH, foundation and industry sponsored grants. His honors include the OCD Foundation Research Award and the Brain and Behavior Distinguished Investigator Award, and he has been listed in the Best Doctors in America for the last 20 years. He was a Visiting Professor and collaborator with Brigham and Women’s Hospital, Harvard Medical School, investigating Focused Ultrasound Pulsation effects on the brain using fMRI, and has authored several patents on image-guided neuromodulation using Low Intensity Focused Ultrasound Pulsation (LIFUP). He directs the collaborative Targeted Brain Stimulation clinical and research program with the department of Neurosurgery at UCLA, is Executive Director of Tiny Blue Dot Foundation, and is Founder and CEO of Brainsonix Corporation.

Dr. Bobby Mehta, Ph.D

Dr. Bobby Mehta, Ph.D

Agri & Bio Engg. Former president of the technology division of a large American diversified company & Founder and CEO of Executive Cardiac Care Co. Dr. Mehta’s background includes the development of ethylene, polyethylene, ethanol, collagen plants and many diverse technologies including Enhanced External Counter-pulsation for treating coronary artery disease patients. Involved in developing genetics, stem cell and exosome based therapies.